Image For Activity Cover
CUC 2022 Webcast: Non-Insulin Therapy Updates


  • Discuss key recommendations from the 2022 ADA Standards of Medical Care in Diabetes related to use of non-insulin glucose-lowering therapies;

  • Review key safety, tolerability, and risk-mitigation strategies to consider with non-insulin glucose-lowering therapies; and

  • Emphasize the importance of diabetes self-management education to optimize use of non-insulin therapies.


Joshua J. Neumiller, PharmD, CDCES, FADCES

Professor of Pharmacotherapy

College of Pharmacy & Pharmaceutical Sciences

Washington State University

Spokane, WA, USA

Availability: On-Demand
Cost: Member: $10.00
Non-Member: $15.00
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ACPE Credit
1 ANCC Credit
1 AAPA Credit
1 CDR Credit
1 COP Credit
American Diabetes Association 2451 Crystal Drive, Suite 900, Arlington, VA 22202 1-800-DIABETES
Follow us on
Copyright 2021. All rights reserved.
Powered By